LMAT insider sale: 2,500 shares sold for $235,000 on 08/08/2025

LeMaitre Vascular, Inc. Form 144 reports a proposed sale of 2,500 common shares on NASDAQ through Morgan Stanley Smith Barney LLC with an aggregate market value of $235,000 and an approximate sale date of 08/08/2025.

Rhea-AI Filing Summary

LeMaitre Vascular, Inc. Form 144 reports a proposed sale of 2,500 common shares on NASDAQ through Morgan Stanley Smith Barney LLC with an aggregate market value of $235,000 and an approximate sale date of 08/08/2025. The filing lists 22,637,522 shares outstanding, showing the reported sale is a very small fraction of the companys outstanding stock.

The securities-to-be-sold were recorded as acquired by a stock option exercise on 08/08/2025 with payment in cash. The filing also discloses a prior sale by Bridget A Ross of 3,750 shares on 05/12/2025 for $312,000. Several filer identification fields (for example Filer CIK and Filer CCC) are not populated in the provided text. The signer affirms no undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Routine insider option exercise and sale; transaction size is negligible relative to outstanding shares, so likely neutral market impact.

The Form 144 documents a sale of 2,500 shares valued at $235,000. With 22,637,522 shares outstanding the sale equals roughly 0.011% of outstanding shares, which is immaterial in size and unlikely to affect liquidity or valuation. The shares were acquired the same day via a stock option exercise and paid in cash, and the sale will be executed through Morgan Stanley Smith Barney LLC. The filing also discloses a prior related sale of 3,750 shares on 05/12/2025. Overall this constitutes routine insider activity rather than a material corporate event.

Corporate Governance Expert

TL;DR: Filing appears procedurally compliant with Rule 144 disclosures; missing filer identification fields are noted in the provided text.

The notice includes the required representations, including a signers declaration that no undisclosed material adverse information exists. The transaction details state acquisition via a stock option exercise and sale through an identified broker on 08/08/2025. The provided excerpt lacks some administrative filer identifiers (for example Filer CIK and Filer CCC appear blank), which are important for tracing the filer but do not change the reported economic facts. Impact on governance or control appears minimal based on the stated quantities.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filed for LMAT report?

The Form 144 reports a proposed sale of 2,500 common shares on NASDAQ through Morgan Stanley Smith Barney LLC for an aggregate market value of $235,000 with approximate sale date 08/08/2025.

How were the 2,500 LMAT shares acquired?

The filing states the 2,500 shares were acquired via a stock option exercise on 08/08/2025 and payment was made in cash.

Has the filer sold LMAT shares recently?

Yes. The document shows Bridget A Ross sold 3,750 shares on 05/12/2025 for gross proceeds of $312,000.

What broker is handling the proposed sale?

The sale is to be handled by Morgan Stanley Smith Barney LLC Executive Financial Services located at 1 New York Plaza 8th Floor New York NY 10004.

Are issuer and filer identification fields complete in the provided filing excerpt?

No. Several administrative fields such as Filer CIK and Filer CCC are not populated in the provided text.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/08/2025 - 04:22 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001698518
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	LEMAITRE VASCULAR, INC.
SEC File Number	001-33092
Address of Issuer	63 Second Avenue Burlington MASSACHUSETTS 01803
Phone	(781) 221-2266
Name of Person for Whose Account the Securities are To Be Sold	BRIDGET A ROSS
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2500	235000.00	22637522	08/08/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/08/2025	Stock Option Exercise	Issuer			2500	08/08/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
BRIDGET A ROSS 63 Second Avenue Burlington MA 01803	Common	05/12/2025	3750	312000.00

144: Remarks and Signature

Remarks
Date of Notice	08/08/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Bridget A Ross
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)